Dosiomics and Radiomics Guided Precision Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Patients

被引：0
|
作者：
Cui, Y. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2250
引用
收藏
页码：E112 / E113
页数：2
相关论文
共 50 条
  • [31] The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
    Park, Seong Yong
    Kim, Hong Kwan
    Jeon, Yeong Jeong
    Lee, Junghee
    Cho, Jong Ho
    Choi, Yong Soo
    Shim, Young Mog
    II Zo, Jae
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1231 - 1239
  • [32] Neoadjuvant immune checkpoints inhibitors plus chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
    Kao, M-W.
    Hsieh, K-C.
    Rau, K-M.
    Ho, H-J.
    Huang, K-K.
    Kuo, Y-H.
    Hsieh, M-C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1539 - S1539
  • [33] Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy
    Yushi Nagaki
    Satoru Motoyama
    Yusuke Sato
    Akiyuki Wakita
    Hiromu Fujita
    Yoshihiro Sasaki
    Kazuhiro Imai
    Yoshihiro Minamiya
    BMC Cancer, 21
  • [34] Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
    Wu, Yingji
    Chen, Jinbin
    Zhao, Lei
    Li, Qiaoqiao
    Zhu, Jinhan
    Yang, Hong
    Guo, Suping
    Xi, Mian
    CANCER RESEARCH AND TREATMENT, 2021, 53 (01): : 172 - 183
  • [35] Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
    Chen, Zhifu
    Wang, Yan
    Chen, Jun
    Xu, Zijun
    Zhang, Tingjuan
    Sun, Lu
    Zhu, Lihua
    Xu, Liben
    Wu, Chaoyang
    Qiu, Zhiyuan
    Wang, Dianjun
    Wu, Ting
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [36] Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy
    Nagaki, Yushi
    Motoyama, Satoru
    Sato, Yusuke
    Wakita, Akiyuki
    Fujita, Hiromu
    Sasaki, Yoshihiro
    Imai, Kazuhiro
    Minamiya, Yoshihiro
    BMC CANCER, 2021, 21 (01)
  • [37] The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
    Park, Seong Yong
    Hong, Min Hee
    Kim, Hye Ryun
    Lee, Chang Geol
    Cho, Jae Ho
    Cho, Byoung Chul
    Kim, Dae Joon
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6426 - 6434
  • [38] CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients
    Fan, Liyuan
    Yang, Zhe
    Chang, Minghui
    Chen, Zheng
    Wen, Qiang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [39] Neoadjuvant chemo-immunotherapy versus neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Wang, X.
    Fang, M.
    Jiang, Y.
    Tao, K.
    Ji, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S165 - S165
  • [40] Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma - A single institutional study
    Lee, JL
    Kim, SB
    Jung, HY
    Park, SI
    Kim, DK
    Kim, JH
    Song, HY
    Kim, WK
    Lee, JS
    Min, YI
    ACTA ONCOLOGICA, 2003, 42 (03) : 207 - 217
12345